
Provider of technical platforms
VCBeat (WeChat ID: vcbeat) learned from foreign media that Revenue Management Solutions (RMS), a provider of payment technology solutions, recently announced the acquisition of i8 Health Solutions (hereinafter referred to as “i8”), a health solutions provider. The specific financial terms of the deal were not disclosed. RMS has long been backed by private equity firm Thompson Street Capital Partners (TSCP), and this acquisition was completed with TSCP’s support.
i8 Health Solutions is a technology platform provider that enables accurate reconciliation of payments posted to the general ledger within clients’ patient accounting systems. The company was founded in 2016 and is headquartered in Ohio, United States.
RMS, founded in 2006 and headquartered in Oklahoma, USA, is a leading developer of medical remittance automation platforms. Currently, the company manages revenue cycle operations for over 1,000 acute care facilities, providing optimized remittance matching, reconciliation, and management services to healthcare providers such as dental practices and pharmacies. The company processes nearly 14 million transactions per month, delivering technology-driven solutions directly to clients and maintaining strong channel partnerships with leading financial institutions in the United States.
Following this acquisition, RMS will systematically expand its platform technology to i8’s customer base and add “General Ledger Posting Solutions” to the RMS platform. Meanwhile, i8’s founders, Scott Thompson and Chip Moore, will remain with the company.
Through the integration of RMS and i8, RMS will manage over 160 million healthcare payment transactions annually across the entire healthcare remittance sector, with total healthcare expenditures on the platform projected to exceed $100 billion per year in the future.
Scott Thompson stated, “We are delighted to partner with RMS. Following this merger, we will offer advanced technological solutions in the market. Our combined business expertise will create significant opportunities for our customers to achieve more efficient cash reconciliation and posting process management.”
RMS CEO Scott Thomas stated, “Acquisitions have always been a key investment focus for TSCP. We are thrilled to integrate i8’s technology into the RMS platform. This acquisition will further enhance RMS’s healthcare remittance solutions, enabling RMS and i8 to join forces in delivering leading-edge technological solutions to our combined customer base.”
Brian Kornmann, Managing Director of TSCP, added, “We have greatly enjoyed our partnership with RMS since our initial investment in 2017. This acquisition represents a key step in continuing to develop RMS’s technology offerings and expanding our product portfolio into the healthcare market. In summary, we believe that RMS and i8 Health Solutions will continue to deliver leading, technology-driven integrated solutions to the market—capabilities that currently cannot be matched by manual management of complex healthcare remittances.”
(Compiled by Wang Chan)